Clinical trial
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low…
NCT00338312 · Warner Chilcott, Industry · Completed
Key facts
| NCT number | NCT00338312 |
|---|---|
| Title | Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido |
| Official title | A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 52 Weeks and Safety for 52 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy. |
| Lead sponsor | Warner Chilcott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypoactive Sexual Desire Disorder |
| Intervention type | Drug |
| Interventions | Testosterone Transdermal System, Placebo patch |
| Enrollment | 610 |
| Start date | Jun 1, 2002 |
| Primary completion | Dec 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Apr 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: